In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019

Cefiderocol was evaluated by broth microdilution versus 1,050 highly antimicrobial-resistant Pseudomonas aeruginosa clinical isolates from the CANWARD study (2007 to 2019). Overall, 98.3% of isolates remained cefiderocol susceptible (MIC, ≤4 μg/mL), including 97.4% of extensively drug-resistant (XDR...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A., Walkty, Andrew J., Baxter, Melanie R., Adam, Heather J., Lagacé-Wiens, Philippe R. S., Schweizer, Frank, Bay, Denice, Lynch, Joseph P., Mulvey, Michael R., Zhanel, George G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430561/
https://www.ncbi.nlm.nih.gov/pubmed/35758747
http://dx.doi.org/10.1128/spectrum.01724-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430561/
https://www.ncbi.nlm.nih.gov/pubmed/35758747
http://dx.doi.org/10.1128/spectrum.01724-22

Ejemplares similares